Clincosm LogoSign in Get a demo

dermatomyositis, adult type

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dermatomyositis, Adult Type Trial (Itolizumab)

Not yet recruiting
  • Dermatomyositis, Adult Type
  • (no location specified)
Aug 3, 2023

Dermatomyositis, Adult Type, Interstitial Lung Disease Trial in Nanjing (triple therapy, dual-therapy)

Recruiting
  • Dermatomyositis, Adult Type
  • Interstitial Lung Disease
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
May 20, 2022

Dermatomyositis, Adult Type Trial in Xi'an (JAK Inhibitor)

Recruiting
  • Dermatomyositis, Adult Type
  • JAK Inhibitor
  • Xi'an, Shaanxi, China
    Department of Rheumatology, the First Affiliated Hospital of Xi'
Jul 15, 2021

Dermatomyositis, Adult Type Trial in New Orleans (Apremilast 30mg)

Completed
  • Dermatomyositis, Adult Type
  • Apremilast 30mg
  • New Orleans, Louisiana
    Tulane University
Jul 7, 2021